loader2
Partner With Us NRI

Parmax Pharma Ltd share Price Today

Company details

30.00
32.99
24.18
37.90
6M Return -6.39%
1Y Return 1.35%
Mkt Cap.(Cr) 11.56
Volume 2,444
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 2,444

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Parmax Pharma Ltd shares SWOT Analysis

Strengths (3)

  • Growth in Net Profit with increasing Profit Margin (QoQ)
  • Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
  • Company with Zero Promoter Pledge

Weakness (11)

  • Companies with High Debt
  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Inefficient use of shareholder funds - ROE declining in the last 2 years

Opportunity (1)

  • Stock with Low PE (PE < = 10)

Threats (0)

Data not found

Resistance and support

R1 32.6
R2 34.3
R3 35.6
Pivot

31.29

S1 29.6
S2 28.3
S3 26.6
EMA SMA
30.3
30.4
30.6
31.0
30.1
30.5
30.7
31.0
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
Name Category Shares
ALKESH MAHASUKH GOPANI PROMOTER 17.95%
VIPUL MAHASUKHLAL GOPANI PROMOTER 12.87%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Parmax Pharma Ltd Stocks COMPARISON

Financials( in Cr) Parmax Pharma Ltd Sun Pharmaceuticals Industries Ltd Divis Laboratories Ltd Cipla Ltd Zydus Lifesciences Ltd
Price 30.89 1,568.40 4,629.70 1,509.90 1,162.45
% Change -4.45 0.67 1.88 1.97 2.23
Mcap Cr 11.56 376,311.70 122,904.18 121,904.34 116,969.67
Revenue TTM Cr 15.42 43,885.68 7,767.51 15,790.60 17,237.40
Net Profit TTM Cr -0.10 8,560.84 1,823.38 2,513.47 1,997.30
PE TTM 0.00 37.61 76.78 28.63 30.34
1 Year Return 1.35 49.54 30.41 49.22 102.48
ROCE 4.03 16.79 19.30 14.76 16.25
ROE -1.69 16.46 14.89 10.66 14.05
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 5.85 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 32,034.54 42,550.31
LAST 3M 115,875.16 11,073.47
LAST 6M 199,586.16 4,620.47
LAST 12M 310,244.99 83,919.34

Parmax Pharma Ltd Information

Stock PE (TTM)
0
Promoter Holding
30.83%
Book Value
-1.627
ROCE
4.03%
ROE
-1.69%
Description
  • Incorporated in Nov.`94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara. The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax`s pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc. The Company then discontinued their business activities for few years due to various reasons. Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994; the Company had set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA. Antibiotic project was fully implemented from 31st May`97.

Registered Address

Plot No 20 Survey No 52, Tal Kotda Sangani Hadamtala, Rajkot, Gujarat, 360311

Tel : 91-2827-270534/535
Email : info:parmaxpharma.com
Website : http://www.parmaxpharma.com
Registrar

Mavji Haribhai Sec & Serv P Lt

AGM Date (Month) : Oct
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 540359
NSE Code :
Book Closure Date (Month) : Sep
BSE Group : X
ISIN : INE240T01014

FAQ’s on Parmax Pharma Ltd Shares

You can buy Parmax Pharma Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Parmax Pharma Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jul 05, 2024 04:01 PM the closing price of Parmax Pharma Ltd was Rs.30.89.

The latest PE ratio of Parmax Pharma Ltd as of Jul 05, 2024 04:01 PM is 0.00

The latest PB ratio of Parmax Pharma Ltd as of Jul 05, 2024 04:01 PM is -0.05

The 52-week high of Parmax Pharma Ltd share price is Rs. 37.90 while the 52-week low is Rs. 24.18

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jul 05, 2024 04:01 PM, the market cap of Parmax Pharma Ltd stood at Rs. 11.56 Cr.

Download App

Download Our App

Play Store App Store
market app